Skip to main content
SpringerLink
Log in

Isotretinoin: no increased risk of IBD

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yu C-L, et al. Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis. American Journal of Clinical Dermatology : 03 Apr 2023. Available from: URL: https://doi.org/10.1007/s40257-023-00765-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isotretinoin: no increased risk of IBD. Reactions Weekly 1953, 7 (2023). https://doi.org/10.1007/s40278-023-37442-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37442-6

Search

Navigation